Evidence map›Paper›PMID 34815751›Full record

ReviewEuropean cardiology2021

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1

Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, Doreen Tan, Dmitry Duplyakov, Ayman Hammoudeh, Bo Zhang, Yi Li, Kai Xu, Paul J Ong and 20 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in European cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 16 institutions in 19 countries.

Jack Wei Chieh TanNational Heart Centre Singapore.
Derek P ChewCollege of Medicine and Public Health, Flinders University Adelaide, Australia.
Kin Lam TsuiPamela Youde Nethersole Eastern Hospital Hong Kong, China.
Doreen TanDepartment of Pharmacy, Faculty of Science, National University of Singapore Singapore.
Dmitry DuplyakovSamara Regional Cardiology Dispensary Samara, Russia.
Ayman HammoudehCardiology Department, Istishari Hospital Amman, Jordan.
Bo ZhangDepartment of Cardiology, First Affiliated Hospital, Dalian Medical University Dalian, China.
Yi LiDepartment of Cardiology, General Hospital of Northern Theatre Command Shenyang, China.
Kai XuDepartment of Cardiology, General Hospital of Shenyang Military Shenyang, China.
Paul J OngHeart Specialist International, Mount Elizabeth Novena Hospital Singapore.
Doni FirmanHarapan Kita National Cardiovascular Center/Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia Harapan Kita Jakarta, Indonesia.
Habib GamraCardiology Department, Fattouma Bourguiba University Hospital and University of Monastir Monastir, Tunisia.
Wael AlmahmeedCleveland Clinic Abu Dhabi United Arab Emirates.
Jamshed DalalCentre for Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital Mumbai, India.
Li-Wah TamKwong Wah Hospital Hong Kong, China.
Gabriel StegDepartment of Cardiology, Hôpital Bichat Paris, France.
Quang N NguyenDepartment of Cardiology, Hanoi Medical University Hanoi, Vietnam.
Junya AkoDepartment of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara, Kanagawa, Japan.
Jassim Al SuwaidiAdult Cardiology, Hamad Medical Corporation Doha, Qatar.
Mark ChanNational University Heart Centre Singapore.
Mohamed SobhyFaculty of Medicine, Alexandria University Egypt.
Abdulla ShehabCollege of Medicine and Health Sciences, UAE University, Al Ain United Arab Emirates.
Wacin BuddhariKing Chulalongkorn Memorial Hospital Bangkok, Thailand.
Zulu WangDepartment of Cardiology, General Hospital of Shenyang Military Shenyang, China.
Alan Yean Yip FongSarawak Heart Centre, Kota Samarahan Malaysia.
Bilgehan KaradagIstanbul University-Cerrahpasa School of Medicine Istanbul, Turkey.
Byeong-Keuk KimDivision of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine Seoul, South Korea.
Usman BaberUniversity of Oklahoma Health Sciences Center Oklahoma City, OK, US.
Chee Tang ChinNational Heart Centre Singapore.
Ya Ling HanDepartment of Cardiology, General Hospital of Northern Theatre Command Shenyang, China.
General Hospital of Shenyang Military Region · CNDalian Medical University · CNFlinders University · AUHanoi Medical University · VNIstanbul University-Cerrahpaşa · TRJordan Hospital · JOKing Chulalongkorn Memorial Hospital · THKwong Wah Hospital · CNMount Elizabeth Novena Hospital · SGNational University Heart Centre Singapore · SGNational University of Singapore · SGPamela Youde Nethersole Eastern Hospital · CNSarawak Biodiversity Centre · MYUnited Arab Emirates University · AEUniversity of Indonesia · IDYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modification of therapy, especially among Asians, who have displayed characteristics that are clinically distinct from Western patients. Previous guidance has been provided regarding the classification of high-risk CCS and the use of newer-generation P2Y

Indexed as

Asiacomorbidityconsensusdual antiplatelet therapymyocardial ischaemiaPlatelet aggregation inhibitors

Identifiers

PMID34815751
PMCPMC8591619
OpenAlexW3214239493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.